| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
| ― | £6.01M | -0.43 | -263.11% | ― | -100.00% | 40.63% | |
71 Outperform | £56.28M | 13.24 | 10.95% | ― | 7.46% | 6.36% | |
65 Neutral | £222.99M | 33.44 | 9.96% | 3.78% | 1.57% | -70.10% | |
41 Neutral | £915.21K | -0.96 | -21.81% | ― | -25.00% | 52.94% | |
40 Underperform | £2.04M | -0.20 | 6.74% | ― | -43.88% | -879.38% |